Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Improve Care for Cancer Patients
NCT ID: NCT02645357
Last Updated: 2017-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15431 participants
INTERVENTIONAL
2015-11-30
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The ONCO-CODES (Computerized DEcision Support in ONCOlogy) trial is a pragmatic, parallel group, randomized controlled study with 1:1 allocation ratio Study Duration 12 month Study Center(s) Single-center
Objectives:
The primary outcome of this trial is a process outcome. i.e. the rate at which the issues reported by the reminders are resolved (resolution rates).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Quality With Outpatient Decision Support
NCT00225628
Impact of a Patient Decision Aid Intervention
NCT05573022
Computerized Decision Support System Linked to Electronic Health Records to Improve Patient Care in a General Hospital
NCT02577198
Health Literacy Intervention for Informed Consent of Cancer Patients Considering Clinical Trial Participation
NCT01964222
Testing the Helpfulness of 2 Decision Aids for Prostate Cancer
NCT00432601
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Short Title/Acronym ONCO-CODES Protocol Code IRST100.23
Rationale:
Computerized decision support systems (CDSSs) are computer programs that provide clinicians, staff, patients, or other individuals with person-specific, actionable recommendations or management options that are intelligently filtered or presented at appropriate times to enhance health and health care. CDSSs might be integrated with patient electronic health records (EHRs) and evidence-based knowledge. The Investigators designed a pragmatic randomized controlled trial to evaluate the effectiveness of patient-specific, point-of-care reminders generated by the Medilogy Decision Support System (MediDSS) on clinical practice and the quality of care in the Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS. The Investigators hypothesize that MediDSS reminders can increase clinician adherence to guidelines and, eventually, improve the quality of care offered to hospitalized patient. The adoption of CDSSs is likely to increase across healthcare systems due to growing concerns about the quality of medical care and discrepancy between real and ideal practice, continuous calls for a meaningful use of health information technology, and the increasing use of and familiarity with advanced technology among new generations of physicians.
Study Design:
The ONCO-CODES (Computerized DEcision Support in ONCOlogy) trial is a pragmatic, parallel group, randomized controlled study with 1:1 allocation ratio Study Duration 12 month Study Center(s) Single-center
Objectives:
The primary outcome of this trial is a process outcome. i.e. the rate at which the issues reported by the reminders are resolved (resolution rates).
Number of Subjects:
The investigators calculated the sample size on the basis of the primary outcome. A sample of 1,704 reminders will be necessary to detect the difference between the two groups (power = 0.90; α =0.05, two-sided; 1:1 allocation). Since estimates for intracluster correlation are not available, Implementing an evidence-based computerized decision support system linked to electronic health records to improve care for cancer patients.
Diagnosis and Main Inclusion Criteria:
The investigators will include all the patients admitted to the facilities of the IRST IRCCS. There are no exclusion criteria
Statistical Methodology:
All analyses will follow the intention-to-treat principle: patients will be analyzed in the group to which they have been randomized. Descriptive statistics will be presented.
All statistical tests will be two-sided. The investigators will use the Stata software to perform all statistical analyses (Stata Corp., College Station, TX, USA).The investigators increased the required sample size (by 20%) to 2,046 reminders to account for clustering by patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
computer reminders on clinical practice
on-screen, point-of-care computer reminders on clinical practice.
computer reminders on clinical practice
on-screen, point-of-care computer reminders on clinical practice.
Control group
No on-screen, point-of-care computer reminders on clinical practice.
Control group
control group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
computer reminders on clinical practice
on-screen, point-of-care computer reminders on clinical practice.
Control group
control group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Italy
OTHER_GOV
University of Milan
OTHER
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
OTHER
Catholic University of the Sacred Heart
OTHER
Duodecim, Finnish Medical Association, Helsinki
UNKNOWN
Mario Negri Institute for Pharmacological Research
OTHER
Ottawa Hospital Research Institute
OTHER
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alessandro Passardi, MD
Role: PRINCIPAL_INVESTIGATOR
IRST IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oncologia Medica, IRST IRCCS, Meldola
Meldola, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Moja L, Passardi A, Capobussi M, Banzi R, Ruggiero F, Kwag K, Liberati EG, Mangia M, Kunnamo I, Cinquini M, Vespignani R, Colamartini A, Di Iorio V, Massa I, Gonzalez-Lorenzo M, Bertizzolo L, Nyberg P, Grimshaw J, Bonovas S, Nanni O. Implementing an evidence-based computerized decision support system linked to electronic health records to improve care for cancer patients: the ONCO-CODES study protocol for a randomized controlled trial. Implement Sci. 2016 Nov 25;11(1):153. doi: 10.1186/s13012-016-0514-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRST100.23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.